[HTML][HTML] Attention-deficit/hyperactive disorder updates

M Kessi, H Duan, J Xiong, B Chen, F He… - Frontiers in molecular …, 2022 - frontiersin.org
Background Attention-Deficit/Hyperactive Disorder (ADHD) is the neurodevelopmental
disorder which commonly occurs in children with the prevalence ranging from 3.4% to 7.2 …

[HTML][HTML] Molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: A review

J Quintero, JR Gutiérrez-Casares, C Álamo - Neurology and therapy, 2022 - Springer
Attention-deficit/hyperactivity disorder (ADHD) is a common childhood-onset
neurodevelopmental disorder characterised by persistent inattention, hyperactivity and …

[HTML][HTML] Genetics in the ADHD clinic: how can genetic testing support the current clinical practice?

L Balogh, AJ Pulay, JM Réthelyi - Frontiers in Psychology, 2022 - frontiersin.org
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a
childhood prevalence of 5%. In about two-thirds of the cases, ADHD symptoms persist into …

A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder

A Chaulagain, I Lyhmann, A Halmøy… - European …, 2023 - cambridge.org
BackgroundThere are now hundreds of systematic reviews on attention deficit hyperactivity
disorder (ADHD) of variable quality. To help navigate this literature, we have reviewed …

[PDF][PDF] Multi-omics approach reveals dysregulated genes during hESCs neuronal differentiation exposure to paracetamol

M Spildrejorde, A Samara, A Sharma, M Leithaug… - Iscience, 2023 - cell.com
Prenatal paracetamol exposure has been associated with neurodevelopmental outcomes in
childhood. Pharmacoepigenetic studies show differences in cord blood DNA methylation …

[HTML][HTML] Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine

SA Roe, DS DeSalve, BJ Piper - Pharmacoepidemiology, 2023 - mdpi.com
Research Question and Objective: While the number of pharmacoepidemiological studies
on stimulant-based ADHD medications has expanded rapidly in recent years, likely due to …

Multi-omics analysis of paracetamol exposure identifies dysregulated genes involved in neurotoxicity and neuronal differentiation of human embryonic stem cells

M Spildrejorde, A Samara, A Sharma, M Leithaug… - bioRxiv, 2022 - biorxiv.org
Background Several epidemiological studies have found associations between long-term
prenatal exposure to paracetamol and neurodevelopmental outcomes in childhood …

Reflection on the future of autism research: the continuum hypothesis-Réflexion sur l'avenir de la recherche sur l'autisme: l'hypothèse du continuum

K Rebecchi - 2023 - osf.io
Since about a century, researchers and clinicians have tried to find a drug treatment,
diagnostic rubrics and therapy to treat autism. Yet, Sukhareva, Kanner and Asperger …

Assessing the safety of medications during pregnancy using multi-omics and a neuronal differentiation model of early human neurodevelopment

M Spildrejorde - 2023 - duo.uio.no
Medications taken during pregnancy may reach the developing fetus and interfere with
neurodevelopmental processes, and possibly increase the risk of disease in later life …

Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden

S Walitza, L Smigielski, M Gerlach - Neuro-/Psychopharmaka im Kindes …, 2023 - Springer
Zusammenfassung Als Psychostimulanzien oder Stimulanzien wird die Gruppe von Neuro‑
/Psychopharmaka bezeichnet, die vorwiegend eine erregende Wirkung auf das zentrale …